Myotonic dystrophy is caused by two different mutations: a (CTG)n expansion in 3' UTR region of the DMPK gene (DM1) and a (CCTG)n expansion in intron 1 of the ZNF9 gene (DM2). The most accredited mechanism for DM pathogenesis is an RNA gain-of-function. Other findings suggest a contributory role of DMPK-insufficiency in DM1. To address the issue of ZNF9 role in DM2, we have analyzed the effects of (CCTG)n expansion on ZNF9 expression in lymphoblastoid cell lines (n=4) from DM2 patients. We did not observe any significant alteration in ZNF9 mRNA and protein levels, as shown by QRT-PCR and Western blot analyses. Additional RT-PCR experiments demonstrated that ZNF9 pre-mRNA splicing pattern, which includes two isoforms, is unmodified in DM2 cells. Our results indicate that the (CCTG)n expansion in the ZNF9 intron does not appear to have a direct consequence on the expression of the gene itself.

Botta, A., Caldarola, S., Vallo, L., Bonifazi, E., Fruci, D., Gullotta, F., et al. (2006). Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1762(3), 329-334 [10.1016/j.bbadis.2005.11.004].

Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)

BOTTA, ANNALISA;CALDAROLA, SARA;VALLO, LAURA;MASSA, ROBERTO;NOVELLI, GIUSEPPE;LORENI, FABRIZIO
2006-03-01

Abstract

Myotonic dystrophy is caused by two different mutations: a (CTG)n expansion in 3' UTR region of the DMPK gene (DM1) and a (CCTG)n expansion in intron 1 of the ZNF9 gene (DM2). The most accredited mechanism for DM pathogenesis is an RNA gain-of-function. Other findings suggest a contributory role of DMPK-insufficiency in DM1. To address the issue of ZNF9 role in DM2, we have analyzed the effects of (CCTG)n expansion on ZNF9 expression in lymphoblastoid cell lines (n=4) from DM2 patients. We did not observe any significant alteration in ZNF9 mRNA and protein levels, as shown by QRT-PCR and Western blot analyses. Additional RT-PCR experiments demonstrated that ZNF9 pre-mRNA splicing pattern, which includes two isoforms, is unmodified in DM2 cells. Our results indicate that the (CCTG)n expansion in the ZNF9 intron does not appear to have a direct consequence on the expression of the gene itself.
mar-2006
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/11 - BIOLOGIA MOLECOLARE
English
Con Impact Factor ISI
RNA Splicing; Humans; In Situ Hybridization, Fluorescence; Recombinant Fusion Proteins; RNA Precursors; Lymphocytes; Protein Isoforms; DNA Repeat Expansion; Phenotype; Base Sequence; Cells, Cultured; RNA-Binding Proteins; Myotonic Dystrophy; Introns; Molecular Sequence Data; Zinc Fingers; Gene Expression Regulation; Mutation
Botta, A., Caldarola, S., Vallo, L., Bonifazi, E., Fruci, D., Gullotta, F., et al. (2006). Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1762(3), 329-334 [10.1016/j.bbadis.2005.11.004].
Botta, A; Caldarola, S; Vallo, L; Bonifazi, E; Fruci, D; Gullotta, F; Massa, R; Novelli, G; Loreni, F
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/38832
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 40
social impact